|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-26
|
|
pubmed:abstractText |
Autoantibodies against the glycoproteins desmogleins 1 and 3 which are components of the desmosomal adhesion complex have been shown to be responsible for the loss of epidermal adhesion characteristic of pemphigus. Elimination of these antibodies should clinically improve the pathology of this group of severe autoimmune blistering skin disorders.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
149
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
598-605
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14510995-Autoantibodies,
pubmed-meshheading:14510995-Cadherins,
pubmed-meshheading:14510995-Combined Modality Therapy,
pubmed-meshheading:14510995-Desmoglein 1,
pubmed-meshheading:14510995-Desmoglein 3,
pubmed-meshheading:14510995-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:14510995-Humans,
pubmed-meshheading:14510995-Immunosorbents,
pubmed-meshheading:14510995-Immunosuppression,
pubmed-meshheading:14510995-Pemphigus,
pubmed-meshheading:14510995-Polyvinyl Alcohol,
pubmed-meshheading:14510995-Treatment Outcome,
pubmed-meshheading:14510995-Tryptophan
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber.
|
|
pubmed:affiliation |
Department of Dermatology, University Hospital of Erlangen, Hartmannstr. 14, D-91052 Erlangen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
